Goldman Sachs’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,300
| Closed | -$3.97M | – | 6813 |
|
|
2021
Q1 | $3.97M | Sell |
18,300
-23,600
| -56% | -$4.44M | ﹤0.01% | 3350 |
|
|
2020
Q4 | $4.84M | Hold |
41,900
| – | – | ﹤0.01% | 3027 |
|
|
2020
Q3 | $4.08M | Buy |
41,900
+5,900
| +16% | +$679K | ﹤0.01% | 3061 |
|
|
2020
Q2 | $4.42M | Hold |
36,000
| – | – | ﹤0.01% | 2885 |
|
|
2020
Q1 | $3.15M | Sell |
36,000
-30,000
| -45% | -$3.18M | ﹤0.01% | 2991 |
|
|
2019
Q4 | $6.9M | Buy |
66,000
+30,000
| +83% | +$3.36M | ﹤0.01% | 2710 |
|
|
2019
Q3 | $4.14M | Buy |
+36,000
| New | +$5.46M | ﹤0.01% | 3000 |
|
|
2018
Q1 | – | Sell |
-30,000
| Closed | -$3.96M | – | 6533 |
|
|
2017
Q4 | $3.96M | Buy |
+30,000
| New | +$3.52M | ﹤0.01% | 3229 |
|
|
2017
Q1 | – | Sell |
-255,000
| Closed | -$28.5M | – | 7106 |
|
|
2016
Q4 | $28.5M | Buy |
+255,000
| New | +$30.7M | 0.01% | 1702 |
|
|
2016
Q3 | – | Sell |
-38,500
| Closed | -$3.52M | – | 7260 |
|
|
2016
Q2 | $3.52M | Sell |
38,500
-163,800
| -81% | -$13.8M | ﹤0.01% | 3148 |
|
|
2016
Q1 | $14.6M | Buy |
202,300
+127,300
| +170% | +$6.98M | ﹤0.01% | 1947 |
|
|
2015
Q4 | $5.21M | Hold |
75,000
| – | – | ﹤0.01% | 2780 |
|
|
2015
Q3 | $6.85M | Buy |
+75,000
| New | +$8.34M | ﹤0.01% | 2588 |
|
|
2014
Q2 | – | Sell |
-10,000
| Closed | -$594K | – | 7207 |
|
|
2014
Q1 | $594K | Buy |
+10,000
| New | +$595K | ﹤0.01% | 5131 |
|
Other funds holding GWPH
Goldman Sachs's GWPH Position: Q2 2021 in Review
Goldman Sachs sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 52,242 shares — an estimated $11.3M sold.
Goldman Sachs first reported a position in GWPH in Q1 2014 and held it in 28 quarters. The position peaked at $27.3M in Q4 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Goldman Sachs reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Goldman Sachs sold 52,242 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $11.3M.
- Goldman Sachs first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 28 quarters.
- Goldman Sachs's GW Pharmaceuticals Plc American Depositary Shares position peaked at $27.3M in Q4 2016.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.